Clinical Cardiology Alert – June 1, 2003
June 1, 2003
View Issues
-
More Favorable Statin Data
The lipid-lowering arm of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) was initially reported at the American College of Cardiology meeting in Chicago in March and subsequently in Lancet. -
Timing of Surgery for Chronic Aortic Regurgitation
Waiting for symptom development before recommending valve replacement surgery in young patients with severe aortic regurgitation due to rheumatic disease resulted in an overall 91% survival, free of symptoms over 10 years. -
Mitral Valve Repair Durability
The durability of mitral valve repair is not constant, and the progressive incidence of more than trivial regurgitation needs to be considered in selecting a strategy for treating chronic mitral regurgitation. -
Natriuretic Peptides in Aortic Stenosis
Since natriuretic peptide levels are elevated in symptomatic patients with moderate-severe aortic stenosis, they may be useful in the management of asymptomatic patients. -
Value of Detecting High Atrial Rates by Pacemaker Diagnostics
It is possible to use pacemakers to detect symptomatic and asymptomatic nonsustained atrial high-rate episodes, and detection of these atrial high-rate episodes identifies patients at higher risk for death, stroke, and atrial fibrillation. -
Natural History of Hypertrophic Cardiomyopathy in a Large Community-Based Population
Hypertrophic cardiomyopathy in the community is a benign disease associated a relatively low incidence of cardiac death. Syncope and left ventricular outflow tract obstructions are the 2 factors associated with sudden death or functional deterioration, respectively. -
Pharmacology Watch: Pneumococcal Vaccine Ineffective at CAP Prevention
Pneumococcal vaccine protects older adults from developing pneumococcal bacteremia but does not prevent community-acquired pneumonia (CAP), according to a new study from Group Health Cooperative in Seattle. -
Clinical Briefs in Primary Care Supplement